Evidence-based approach best for cancer management tools

October 1, 2001

Anaheim, Calif. - Topical imiquimod, systemic retinoids, and sentinellymph node biopsies are dermatologic tools that instigate promise and controversywhen discussing their role in managing basal cell carcinoma, squamous cellcarcinoma, and primary cutaneous melanoma, respectively.